Fertility Apps and Wearables: Do They Actually Help?

The honest picture, with numbers

Cycle-tracking apps are among the most downloaded health products in the world, and most of them have never been validated against a clinical measure of ovulation. Some wearable devices have. Keeping those two facts apart is the whole of this page.

Start with what a tracker is trying to do. The fertile window is the 6-day interval ending on the day of ovulation. An app that predicts that window from your previous cycle lengths is making a statistical guess about a future event; a device that measures a physiological change is detecting something that has already begun. Those are different problems with very different accuracy.

The apps: what testing found

A published assessment scored 12 menstrual cycle apps against eight criteria for identifying the fertile window. The results split cleanly by method:

• Calendar-based apps scored 0 out of 30. They complied with none of the eight criteria, because predicting from previous cycle lengths cannot account for the natural variability of ovulation timing.
• Calculothermal apps — combining calendar data with temperature — scored 3 out of 30 (Ovy) and 2 out of 30 (Natural Cycles) for identifying highly fertile days.
• Symptothermal apps, which use temperature and cervical mucus recorded during the current cycle, did substantially better: 20 out of 30 for Lady Cycle and myNFP, 19 for Lily, 11 for OvuView.

The authors' conclusion is the sentence to remember: apps that predict fertile days from data on previous cycles alone are not suitable for helping couples conceive, because the fertile window has to be determined during the ongoing cycle.

That is a methodological finding, not a brand ranking, and the app market changes constantly. But the principle holds regardless of which app is currently top of the store: if it is extrapolating from your last three cycles, it is guessing.

The wearables: where real validation data exists

Some devices have published accuracy studies, and they are worth reading with their limitations in view.

A 2025 validation analysis of the Oura Ring examined 1,155 ovulatory cycles from 964 participants, using the day after the last positive home LH test as the reference. Its physiology-based method detected ovulation in 96.4% of cycles with a mean absolute error of 1.26 days, identifying 87.9% of ovulation dates within 2 days and 68% within 1 day. The calendar method, run on the same cycles for comparison, had a mean absolute error of 3.44 days and got 50.7% within 2 days. That is roughly a 2.7-fold difference in error.

Now the caveats, which the paper states itself. All three authors are employees of Oura Health. The dataset contained only ovulatory cycles, so it says nothing about how the method performs when you do not ovulate — which for many people trying to conceive is the actual question. The reference standard was self-reported LH tests rather than ultrasound. And the cohort was self-selecting: Oura users who also do LH testing.

A 2024 systematic review of wearable reproductive health technology found only 13 studies in total across the whole field, covering the Oura Ring, the Ava bracelet, OvulaRing, ear-worn and abdominal sensors. Reported accuracy ranged from 83% (Oura, ovulation detection) to 90% (Ava, fertile period) to 88% (OvulaRing, three-day window). The review's conclusions were cautious: many studies were small pilots, more research is needed to validate these devices, some detect only three days before ovulation rather than the full six-day window, and — in the authors' framing — commercial marketing has outpaced rigorous scientific validation. It also flagged privacy as a live concern given the sensitivity of reproductive data.

What the outcome evidence says

Accuracy at detecting ovulation is not the same as helping you get pregnant. For that, the 2023 Cochrane review of timed intercourse (7 trials, 2,464 women) is the relevant evidence:

• Urine ovulation tests probably increase live birth compared with intercourse without ovulation prediction: risk ratio 1.36 (95% CI 1.02 to 1.81), moderate-quality evidence from one trial of 844 participants.
• Fertility awareness-based methods — which Cochrane defines to include basal body temperature tracking, cervical mucus monitoring and calendar charting or tracking apps — showed no clear effect on live birth: RR 0.95 (95% CI 0.76 to 1.20), low-quality evidence from two trials totalling 157 participants.

So the cheap strip of paper has better outcome evidence behind it than any app or ring currently on the market. No wearable has yet been tested in a randomised trial with live birth as an outcome.

What NICE says about the underlying measurements

Two NICE recommendations bear directly on what these products measure. NICE recommends against using basal body temperature charts to confirm ovulation, because they do not reliably predict it — and temperature is exactly what most wearables track, albeit continuously and at a finer resolution than a morning thermometer. NICE's method for confirming ovulation is a mid-luteal serum progesterone blood test, on day 21 of a 28-day cycle, taken later and repeated weekly where cycles are long or irregular.

That is the comparison worth making. A device costing several hundred pounds gives you a probabilistic estimate of when ovulation happened. A blood test arranged through your GP gives a clinical answer, and in the UK costs nothing.

What to do next

1. If you use an app, use it as a diary, not an oracle. A record of your actual cycle lengths and symptoms is genuinely useful at a clinic appointment. Its prediction of next month's fertile window is not evidence.
2. If you want to spend money on timing, buy LH tests first. That is the intervention with moderate-quality live birth evidence, and it costs a fraction of a wearable.
3. Do not use tracking to answer "am I ovulating". Ask for a progesterone blood test timed to your actual cycle length.
4. Interrogate the claim before you buy a device. Ask: is there a published validation study, was it independent of the manufacturer, what was the reference standard, and did it include anovulatory cycles?
5. Check what happens to your data — who it is shared with, how long it is kept, and whether it can be deleted. The systematic review named reproductive data privacy as a specific concern in this category.
6. Have sex every 2 to 3 days anyway. It covers the window without requiring any of this to be accurate.

When to seek help

An app or ring that shows no clear ovulation pattern across several cycles is information, not a diagnosis — but it is a reason to book an appointment rather than buy a better device. Irregular or absent cycles, no temperature shift across several months, or persistent positive LH readings without a pattern all warrant a progesterone test and, where cycles are irregular, serum gonadotrophins.

The standard thresholds still apply: assessment of both partners after 1 year of unprotected vaginal intercourse, and referral at first presentation if the woman trying to conceive is 36 or over, or if either partner has a known or suspected clinical cause. No amount of data collection substitutes for that timeline, and there is a real risk that months of tracking become a reason to postpone the appointment.